We substantially invest in your trial. After an established trial period, only pay for high quality candidates based on the trial’s I/E criteria or choose a capped monthly payment to ensure you stay within budget.
Hire us as your primary recruiter or in addition to your current strategies. There is only the upside possibility that we will help fill the trial more quickly. We can generate leads at lightning speed.
A movement disorders specialized neurologist reviews all candidates recommended to your sites for screening which drastically reduces site workload while increasing the randomization rate.
We deploy one of a kind tactics to augment recruitment to reach a fresh and new audience. Communicate with a million PD patients to make sure your trial fills.
Dr. Rajeev Kumar Evaluates Candidates For Suitability
Our intensive review of each candidate’s suitability includes screening by a well-known and experienced movement disorders specialist who conducts many clinical trials of his own. We only deliver candidates to sites that our reviewer would be comfortable enrolling at his own site. In many trials, we have achieved a zero screen fail rate as result of our rigorous review process.
Our recruiting team can reach over a million people related to Parkinson’s disease in the United States.
We specialize in one thing, neurological clinical trials recruitment. Our success is derived from outstanding and intricate knowledge of the clinical trials process, industry leading expertise in neurology, and mastery of digital communication including social media, pay per click, and organic marketing.
Neurological Clinical Trials Experts
Advanced Digital Marketers
Established Database and Infrastructure
By effectively communicating with over one million people affected by Parkinson’s Disease in the United States, we are able to generate thousands of leads. Our site database already contains many potential subjects who could qualify for your trial. In addition to our highly capable lead generation capacity and ever-growing database, we have the largest Parkinson’s Disease support group on Facebook with over 9,000 members.
Of 1,500,000 people in the U.S. affected by Parkinson’s Disease we have reached 556,952 to date. Our communication is well received as 52,392 people interact with our education materials on social media platforms.
Every campaign is guided by our medical director, a movement disorders trained neurologist who works with your study’s physicians to plan the underlying strategies and tactics that will be deployed.
We use IRB approved materials, HIPAA compliant systems, and operate in a methodology consistent with the intention of law as expressed by HHS and the FDA to provide candidates with the knowledge they need to make an informed decision about participating in research.
We are so confident in our abilities to deliver as promised that we pay all upfront costs including web development, recruitment material creation, HIPAA compliant data basing, lead tracking software, and advertising. You only pay for results. We will fill your trial quickly and within budget.
How We Recruit
Working with pharmaceutical companies, contract research organizations, and local sites to rapidly randomize subjects in the most ethical and regulatory compliant fashion. Versed in clinical trials recruiting, web development, social media marketing, pay per click advertising, email communication, HIPAA compliance, IRB processes, HHS and FDA law.
Substantial Legal Expertise for Clinical Trial Recruitment
Leveraging technology is essential in a digital era but doing so must be done with care. Our regulatory team consists of specialized counsel from Hall Render to support regulatory compliance. Our attorneys have extensive experience advising clients on bench, translational and clinical research-related matters including: legal and regulatory compliance; reporting obligations; intellectual property and technology transfer issues and arrangements; and on the complicated relationships between health care facilities, research institutions, institutional review boards (IRBs), principal investigators, academic institutions and sponsors/grantors.